Filter
2418
Filtered Results: 2418
Text search:
Delta
Featured
Recommendations
197
New Publications
357
Language
Document type
Guidelines
651
No document type
622
Studies & Reports
532
Strategic & Response Plan
173
Manuals
162
Fact sheets
108
Training Material
69
Situation Updates
48
Brochures
22
Infographics
17
Resource Platforms
7
Online Courses
4
Videos
2
Dashboards/Maps
1
Countries / Regions
Latin America and the Carribbean
145
Senegal
112
Global
88
Argentina
84
Burkina Faso
82
Colombia
78
Congo, Democratic Republic of
71
Venezuela
59
Myanmar / Burma
58
Peru
55
Brazil
55
Nigeria
51
Benin
44
Ecuador
41
Paraguay
41
Bolivia
39
Africa
39
Chile
38
Haiti
35
Cameroon
31
Central African Republic
31
El Salvador
27
Mali
26
Mozambique
26
West and Central Africa
26
Guinea
22
Spain
18
Niger
17
Côte d’Ivoire / Ivory Coast
16
Bangladesh
16
Madagascar
15
Angola
14
Uganda
13
India
13
Philippines
12
Germany
12
East and Southern Africa
11
Honduras
10
Guinea-Bissau
9
Ethiopia
9
Chad
9
Kenya
9
Middle East and North Africa
9
Western and Central Europe
9
France
9
Togo
8
Mexico
8
Rwanda
7
Guatemala
7
Sierra Leone
6
South Sudan
6
Uruguay
6
Liberia
5
South Africa
5
Burundi
5
South–East Asia Region
5
Congo-Brazzaville
5
Russia
5
Nepal
4
Zambia
4
Malawi
4
Dominican Republic
4
Botswana
4
Nicaragua
4
Eastern Europe
4
Morocco
3
Somalia
3
Iraq
3
Syria
3
Indonesia
3
Ukraine
3
Eastern Europe and Central Asia
3
Luxembourg
3
Djibouti
3
Canada
3
Belgium
3
Tunisia
3
Zimbabwe
2
Jordan
2
Lebanon
2
Cambodia
2
Mauritania
2
Sudan
2
Namibia
2
Cuba
2
Libya
2
Lesotho
2
Western Pacific Region
2
Asia
2
Vietnam
2
Portugal
2
USA
1
Saudi Arabia
1
Pakistan
1
Afghanistan
1
Turkey
1
Egypt
1
Thailand
1
Papua New Guinea
1
Eswatini/ Swaziland
1
Switzerland
1
Sri Lanka
1
Yemen
1
Italy
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Moldova
1
Iran
1
Kazakhstan
1
North America
1
Gabon
1
Algeria
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1207
Clinical Guidelines
173
Women & Child Health
118
Public Health
94
Key Resources
75
Capacity Building
31
Pharmacy & Technologies
25
Annual Report MEDBOX
1
Toolboxes
COVID-19
609
TB
165
Mental Health
121
Planetary Health
94
Caregiver
88
NTDs
76
AMR
73
Rapid Response
69
HIV
53
Disability
51
Refugee
37
Ebola
34
Pharmacy
28
Natural Hazards
27
Global Health Education
22
Cholera
21
Conflict
20
Social Ethics
17
Health Financing Toolbox
12
NCDs
12
Zika
11
Polio
8
Specific Hazards
2
Typhoon
1
This global progress report attempts to lay the groundwork for the kind of accelerated action needed. Section 1 presents key data, trends and developments in women’s, children’s and adolescents’ health and well-being. That is followed in Section 2 by a deeper dive into the impact of the COVID-...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
January 2020 to December 2021
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding...
This publication is part of WHO 75th anniversary and aims to capture key successes in public health globally and in Namibia. It includes contributory messages from the Head of State, Prime Minister and the Minister of Health and Social Services.
The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris...
